Have a feature idea you'd love to see implemented?
Let us know!
YCBD cbdMD Inc
Price (delayed)
$0.481
Market cap
$1.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.23
Enterprise value
$3.52M
cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical
Highlights
The EPS is up by 38% year-on-year and by 8% since the previous quarter
The net income has increased by 10% YoY and by 10% QoQ
The company's debt fell by 29% QoQ but it rose by 3.1% YoY
YCBD's equity has dropped by 88% year-on-year
The quick ratio has plunged by 53% YoY and by 2.3% from the previous quarter
Key stats
What are the main financial stats of YCBD
Market
Valuations
Earnings
Shares outstanding
3.76M
Market cap
$1.81M
Enterprise value
$3.52M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.17
Revenue
$20.64M
EBIT
-$19.4M
EBITDA
-$16.7M
Free cash flow
-$1.08M
Per share
Balance sheet
Liquidity
EPS
-$11.23
Free cash flow per share
-$0.3
Book value per share
$0.78
Revenue per share
$5.74
TBVPS
$3.1
Total assets
$13.84M
Total liabilities
$10.82M
Debt
$4.11M
Equity
$3.03M
Working capital
-$567,610
Debt to equity
1.36
Current ratio
0.93
Quick ratio
0.42
Net debt/EBITDA
-0.1
Margins
Efficiency
Dividend
EBITDA margin
-80.9%
Gross margin
63.4%
Net margin
-94.1%
Operating margin
-88.3%
Return on assets
-157%
Return on equity
-422.4%
Return on invested capital
-246.2%
Return on capital employed
-324%
Return on sales
-94%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
YCBD stock price
How has the cbdMD stock price performed over time
Intraday
-5.13%
1 week
9.07%
1 month
4.5%
1 year
-49.5%
YTD
-53.75%
QTD
2.34%
Financial performance
How have cbdMD's revenue and profit performed over time
Revenue
$20.64M
Gross profit
$13.09M
Operating income
-$18.22M
Net income
-$19.42M
Gross margin
63.4%
Net margin
-94.1%
The revenue has decreased by 22% YoY and by 4.4% from the previous quarter
cbdMD's gross profit has decreased by 20% YoY and by 3.3% from the previous quarter
cbdMD's operating income has increased by 18% YoY and by 7% from the previous quarter
The company's net margin fell by 14% YoY but it rose by 6% QoQ
Growth
What is cbdMD's growth rate over time
Valuation
What is cbdMD stock price valuation
P/E
N/A
P/B
0.61
P/S
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.17
The EPS is up by 38% year-on-year and by 8% since the previous quarter
YCBD's equity has dropped by 88% year-on-year
The stock's P/B is 28% below its 5-year quarterly average of 0.9 but 8% above its last 4 quarters average of 0.6
YCBD's P/S is 94% below its 5-year quarterly average of 1.4 and 10% below its last 4 quarters average of 0.1
The revenue has decreased by 22% YoY and by 4.4% from the previous quarter
Efficiency
How efficient is cbdMD business performance
The ROA has plunged by 119% YoY and by 21% from the previous quarter
The company's return on equity has shrunk by 85% QoQ
YCBD's ROIC has shrunk by 61% YoY and by 12% QoQ
The ROS is down by 14% year-on-year but it is up by 6% since the previous quarter
Dividends
What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for YCBD.
Financial health
How did cbdMD financials performed over time
The total assets is 28% more than the total liabilities
cbdMD's current ratio has shrunk by 60% YoY and by 13% QoQ
The total assets has plunged by 58% YoY and by 4.9% from the previous quarter
The company's debt is 36% higher than its equity
YCBD's equity has dropped by 88% year-on-year
The company's debt fell by 29% QoQ but it rose by 3.1% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.